Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating peripheral stem cell transplantation with filgrastim in patients with acute or chronic myeloid leukemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 2 | Status: COMPLETED